Getting, Stephen J. and Allcock, Graham H. and Flower, Roderick J. and Perretti, Mauro (2001) Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties. Journal of Leukocyte Biology, 69 (1). pp. 98-104. ISSN 0741-5400Full text not available from this repository.
The effects of the natural and synthetic ligands for the melanocortin receptor type 3 (MC3-R) have been evaluated in a murine model of experimental gout. Systemic treatment of mice with ?2-melanocyte-stimulating hormone (?2-MSH) and the synthetic agonist MTII inhibited accumulation of KC, interleukin-1 beta (IL-1?), and PMN elicited by urate crystals in the peritoneal cavity. In vitro, macrophage (Mø) activation, determined as release of KC and IL-1?, was inhibited by ?2-MSH and MTII. The mixed MC3/4-R antagonist SHU9119 prevented the inhibitory actions of ?2-MSH and MTII in vitro and in vivo, whereas the selective MC4-R antagonist HS024 was without effect. Western blotting also showed the presence of MC3-R protein on murine peritoneal Mø. Furthermore, agonism at the MC3-R evoked accumulation of cAMP within the Mø, which was inhibited by SHU9119. Thus, naturally occurring melanocortins, as well as the synthetic long-acting compound MTII, activate MC3-R on peritoneal Mø to inhibit the experimental inflammatory response.
|Subjects:||University of Westminster > Science and Technology > Life Sciences, School of (No longer in use)|
|Depositing User:||Rachel Wheelhouse|
|Date Deposited:||18 Jul 2012 15:38|
|Last Modified:||18 Jul 2012 15:38|
Actions (login required)
|Edit Item (Repository staff only)|